Benchmarking Sustainability Goals: Pharmaceutical Companies

This report provides a quantitative analysis of the sustainability goals of pharmaceutical industry leaders Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Co, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi and Teva. Published in 2011.

Goals signal intent and drive behavior. Some companies use public announcements of sustainability goals to signal their commitment to become sustainability leaders and to compete for superior positioning with their rivals. There has never been a convenient benchmarking tool to allow sustainability executives to put their own goals in the context of their competitors. Until now.
Purchase this report to learn:

  • How do the pharma companies’ environmental sustainability goals compare?
  • Which sustainability issues are receiving the greatest attention?
  • Which companies are setting the most quantitative, forward-looking goals?
  • And more.

Pages: 11; Figures: 5


Key Questions

Key Finding

Goals and Targets Drive Change and Competitive Differentiation

Major Pharmas’ Goals Are Focused on Operations
Few Goals Deal with Supply Chain or Biodiversity
Wide Disparity in Number of Goals and Target Years
GHG Emissions and Energy Receive the Most Focus

List of Goals



Related Research


Figure 1 Breakdown of Sustainability Goals by Major Area

Figure 2 GSK’s carbon footprint in 2009 (% of CO2e)

Figure 3 Number of Sustainability Goals per Company by Target Year

Figure 4 Percentage of Goals Addressing Each Issue

Figure 5 List of Company Sustainability Goals


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s